Re: [IP] 50% of T1 med professionals use pumps
At 02:54 PM 10/31/03 -0800, you wrote:
>A few years ago there was a study published that showed that 50% or
>more of T1 medical professionals used pumps. I'm trying to track it
>down. If anyone has a link, I'd appreciate it.
>email @ redacted
Is this what you're looking for?
MiniMed: Diabetes Experts Know The Best Kept Secret in Medicine. Recent
Survey Reveals Information Disconnect Between Healthcare Practitioners and
LARCHMONT, N.Y.--(BW HealthWire)--May 22, 2000--A survey published today in
a leading diabetes professional publication revealed that diabetes
specialists treat their own diabetes very differently from the average
The study reveals a wide gap in the quality of care between the average
diabetes patient and a doctor or nurse with diabetes.
The survey published in Diabetes Educator (May/June 2000), titled, "How
Diabetes Specialists Treat Their Own Diabetes: Findings From a Study of the
AADE and ADA Membership," was conducted by an independent research
organization to study how diabetes specialists, who have diabetes, manage
their own care. More than 50 percent of the doctors and nurses with
diabetes reported using insulin pumps rather than traditional syringe therapy.
The survey reported healthcare professionals using insulin pump therapy is
nearly ten times higher than the rate in which the average Type 1 diabetics
use this treatment. The study concluded that better knowledge of the latest
studies, past experience with controlling glycemic levels, and easier
access to diabetes specialists contributed to the dramatic difference.
"This study proves a huge disconnect in the medical community. As doctors,
we have the ability to give diabetes patients the power to keep themselves
much healthier with the current standard of diabetes treatment," said Dr.
Michael Perley, an endocrinologist with Type 1 diabetes.
"It is critical that healthcare systems and general practitioners, who
treat most of the diabetics in this country, take steps to educate their
patients about the importance of tight glycemic control and the various
treatment options available to them including insulin pump therapy."
Type 1 diabetes, also known as insulin dependent diabetes, affects
approximately 1 million people in the United States. Most Type 1 diabetics
are diagnosed as children or young adults. As an autoimmune disease, Type 1
diabetes leaves the body unable to produce insulin -- the hormone crucial
for proper body functioning.
The insulin pump, about the size of a pager, is designed to function almost
like the human pancreas, delivering insulin in small amounts throughout the
The benefits of insulin pump therapy include: improved blood sugar control
during play, work or sleep, increased lifestyle flexibility and a lower
risk of long-term complications including blindness and neuropathy, often
resulting in amputation.
In the study, approximately 12,525 surveys were distributed to all
professional members of the American Association of the Diabetes Educators
(AADE) and the American Diabetes Association (ADA), with instructions for
the survey to be completed by only those individuals with diabetes. Of the
12,525 surveys, 802 were returned.
The prevalence of Type 1 diabetes in this sample was estimated to be higher
than that of the general U.S. population. Of the respondents with Type 1
diabetes, 96 percent practiced intensive treatment regimens.
Intensive management is defined as three or more shots per day or use of an
insulin pump. In the general population less than 25 percent of people with
Type 1 diabetes practice intensive therapy.
The survey confirmed that diabetes specialists treat their own diabetes
according to current standards of medical care as recommended by the
American Diabetes Association -- with insulin pumps being the preferred
method of insulin therapy for Type 1 diabetes in this sample. The study
implies that the average diabetes patient and their doctors -- are unaware
of the current standard of care in America.
"As a physician with Type 1 diabetes, I am an advocate of tight glycemic
control and believe that insulin pump therapy should be the first line of
treatment for this form of the disease," said Dr. Perley.
"This study proves that is incumbent upon the diabetic patient to
communicate concerns about their disease and its effects on their life to
their doctors and nurses. Hopefully, we can narrow the communications gap
between doctor and patient."
Insulin pump therapy has been available since the 1980s as an optional
treatment for Type 1 diabetes. MiniMed in Sylmar, California, is the
leading insulin pump manufacturer in the United States. Insulin pumps are
prescribed by a physician and are supported by comprehensive training for
the patient by a skilled professional.
for HELP or to subscribe/unsubscribe, contact: